The COVID-19 pandemic poses a serious challenge to addiction patients and treatment providers alike. Cordant's pharmacy solution can help ensure patients have convenient and reliable access to buprenorphine and reduce unnecessary travel by delivering the medication to the patient at the time of their visit to the clinic.

Presented by
Demetra Ashley
Former U.S. Drug Enforcement Administration Acting Assistant Administrator, Diversion Control Division | Pharmacy Compliance Officer, Cordant Health Solutions
Bob Mann
Senior VP & GM of Integrated Services, Cordant Health Solutions